Smith+Nephew announced the launch of its RENASYS EDGE Negative Pressure Wound Therapy System in the US as a patient-centric option for treating chronic wounds. The system is lightweight and compact allowing it to be easily carried or worn, it features a discreet canister, and operates quietly so as not to draw attention or disturb the patients’ daily activities. Smith+Nephew is also announcing two new national distribution partners for the RENASYS EDGE System – SunMED Medical Solutions and First Nation Group. These new partnerships will enable Smith+Nephew to introduce this new, innovative technology to more patients on a national level and support its growing negative pressure wound therapy business.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNN:
- Smith+Nephew introduces the RENASYS™ EDGE Negative Pressure Wound Therapy System – an exciting new option in home-based care for patients living with chronic wounds
- Smith & Nephew partners with UFC as sports medicine technology provider
- Smith+Nephew teams up with UFC to be first-ever Preferred Sports Medicine Technology Partner
- Smith & Nephew Snats (SNN) Announces Q2 Dividend: Save the Dates!
- Smith & Nephew price target raised to 1,200 GBp from 1,150 GBp at Barclays
